CN104684562A - 用于改善认知健康和认知功能的植物提取物 - Google Patents

用于改善认知健康和认知功能的植物提取物 Download PDF

Info

Publication number
CN104684562A
CN104684562A CN201380051858.4A CN201380051858A CN104684562A CN 104684562 A CN104684562 A CN 104684562A CN 201380051858 A CN201380051858 A CN 201380051858A CN 104684562 A CN104684562 A CN 104684562A
Authority
CN
China
Prior art keywords
memory
cognitive
extract
samp8
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201380051858.4A
Other languages
English (en)
Chinese (zh)
Inventor
M·切迪亚
K·赫林格尔
B·刘易斯
H·冯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kemin Industries Inc
Original Assignee
Kemin Industries Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kemin Industries Inc filed Critical Kemin Industries Inc
Priority to CN202010406999.5A priority Critical patent/CN111358832A/zh
Publication of CN104684562A publication Critical patent/CN104684562A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/534—Mentha (mint)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
CN201380051858.4A 2012-08-09 2013-08-09 用于改善认知健康和认知功能的植物提取物 Pending CN104684562A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010406999.5A CN111358832A (zh) 2012-08-09 2013-08-09 用于改善认知健康和认知功能的植物提取物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261681414P 2012-08-09 2012-08-09
US61/681,414 2012-08-09
PCT/US2013/054274 WO2014026081A1 (en) 2012-08-09 2013-08-09 Plant extracts for improving cognitive health and function

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN202010406999.5A Division CN111358832A (zh) 2012-08-09 2013-08-09 用于改善认知健康和认知功能的植物提取物

Publications (1)

Publication Number Publication Date
CN104684562A true CN104684562A (zh) 2015-06-03

Family

ID=50066333

Family Applications (2)

Application Number Title Priority Date Filing Date
CN201380051858.4A Pending CN104684562A (zh) 2012-08-09 2013-08-09 用于改善认知健康和认知功能的植物提取物
CN202010406999.5A Pending CN111358832A (zh) 2012-08-09 2013-08-09 用于改善认知健康和认知功能的植物提取物

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN202010406999.5A Pending CN111358832A (zh) 2012-08-09 2013-08-09 用于改善认知健康和认知功能的植物提取物

Country Status (11)

Country Link
US (2) US20140044813A1 (https=)
EP (1) EP2882443B1 (https=)
JP (4) JP2015524484A (https=)
KR (1) KR101947352B1 (https=)
CN (2) CN104684562A (https=)
AU (1) AU2013299491B2 (https=)
BR (1) BR112015002739A2 (https=)
CA (1) CA2880708C (https=)
ES (1) ES2715005T3 (https=)
PL (1) PL2882443T3 (https=)
WO (1) WO2014026081A1 (https=)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106727915A (zh) * 2017-01-18 2017-05-31 云南德彩堂生物医药科技有限公司 一种稳定高效提高记忆的组合物及其制备方法和应用
CN110022872A (zh) * 2016-11-11 2019-07-16 建明工业 植物提取物用于通过增强的神经发生改善脑健康的应用
CN110463846A (zh) * 2019-07-30 2019-11-19 河南科技学院 留兰香提取物在制备抗宠物衰老药物或宠物食品中的应用

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140044813A1 (en) * 2012-08-09 2014-02-13 Kemin Industries, Inc. Plant Extracts for Improving Cognitive Health and Function
JP2017507125A (ja) * 2014-01-30 2017-03-16 ケミン、インダストリーズ、インコーポレーテッドＫｅｍｉｎ Ｉｎｄｕｓｔｒｉｅｓ， Ｉｎｃ． 認知機能を向上させるための植物抽出物
JP2017527591A (ja) * 2014-09-15 2017-09-21 ケミン、インダストリーズ、インコーポレーテッドＫｅｍｉｎ Ｉｎｄｕｓｔｒｉｅｓ， Ｉｎｃ． 認知機能向上のための植物抽出物
MX2017004582A (es) * 2014-10-08 2017-10-12 Abbott Lab Composiciones nutricionales que comprenden un componente oxidable y un extracto de plantas solubles en agua.
EP3703675A4 (en) * 2017-10-30 2021-06-16 Neuropore Therapies, Inc. SUBSTITUTED PHENYLSULFONYLPHÉNYLTRIAZOLETHIONES AND ASSOCIATED USES
CN109602759B (zh) * 2019-01-17 2020-10-09 广西医科大学 罗汉松实多糖的用途
KR102421772B1 (ko) * 2019-05-21 2022-07-18 건국대학교 글로컬산학협력단 클로로필 및 로즈마린산을 포함하는 미세먼지에 의해 유발된 신경염증 또는 신경 퇴행성 질환의 예방 또는 치료용 조성물
JP7330630B2 (ja) * 2019-11-20 2023-08-22 株式会社ニップン ロスマリン酸及びカルノシン酸を有効成分とする神経突起伸長誘導作用を有する組成物
JP2022104122A (ja) * 2020-12-28 2022-07-08 株式会社ニップン オキシトシン関連シグナル活性化剤
JP2026503187A (ja) * 2022-10-27 2026-01-28 ケミン、インダストリーズ、インコーポレーテッド 網膜神経栄養のためのスペアミント抽出物の使用

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1930019A1 (en) * 2006-11-24 2008-06-11 DSMIP Assets B.V. Rosemary extracts, dietary and pharmaceutical compositions containing them and their uses
WO2008090474A2 (en) * 2007-01-24 2008-07-31 University Of Guelph Production of rosmarinic acid from spearmint and uses thereof
WO2009056208A1 (en) * 2007-10-17 2009-05-07 Cognis Ip Management Gmbh Food compositions comprising lemon balm extracts
JP2011256118A (ja) * 2010-06-07 2011-12-22 Kao Corp Ｉｌ−８及びｇｍ−ｃｓｆ発現抑制剤

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999059606A1 (en) * 1998-05-16 1999-11-25 Mogam Biotechnology Research Institute Use of rosmarinic acid and derivatives thereof as an immunosuppressant or an inhibitor of sh2-mediated process
JP4629822B2 (ja) * 1999-12-02 2011-02-09 長瀬産業株式会社 神経成長因子合成促進剤
JP2006199666A (ja) * 2005-01-24 2006-08-03 Nagase & Co Ltd 健忘症の予防・治療剤
EP1940389A2 (en) * 2005-10-21 2008-07-09 Braincells, Inc. Modulation of neurogenesis by pde inhibition
EP1925213A1 (en) * 2006-11-24 2008-05-28 DSMIP Assets B.V. Dietary and pharmaceutical compositions comprising a sage extract comprising a mixture of tricyclic diterpenes and their derivatives and their uses
US7972633B2 (en) * 2007-02-07 2011-07-05 Applied Cognitive Sciences, LLC Nutritional supplements for healthy memory and mental function
AU2010258356B2 (en) * 2009-06-12 2017-01-19 Generex Pharmaceuticals, Inc. Compositions and methods for prevention and treatment of brain diseases and conditions
CN101773488A (zh) * 2010-02-10 2010-07-14 青岛大学 一种基于迷迭香酸的药物及其在治疗帕金森病中的应用
US20140044813A1 (en) * 2012-08-09 2014-02-13 Kemin Industries, Inc. Plant Extracts for Improving Cognitive Health and Function

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1930019A1 (en) * 2006-11-24 2008-06-11 DSMIP Assets B.V. Rosemary extracts, dietary and pharmaceutical compositions containing them and their uses
WO2008090474A2 (en) * 2007-01-24 2008-07-31 University Of Guelph Production of rosmarinic acid from spearmint and uses thereof
WO2009056208A1 (en) * 2007-10-17 2009-05-07 Cognis Ip Management Gmbh Food compositions comprising lemon balm extracts
JP2011256118A (ja) * 2010-06-07 2011-12-22 Kao Corp Ｉｌ−８及びｇｍ−ｃｓｆ発現抑制剤

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DONG HYUN PARK 等: "Subchronic administration of rosmarinic acid, a natural prolyl oligopeptidase inhibitor, enhances cognitive performances", 《FITOTERAPIA》 *
TURSUN ALKAM，等: "A natural scavenger of peroxynitrites, rosmarinic acid, protects against impairment of memory induced by Abeta25–35", 《BEHAVIOURAL BRAIN RESEARCH》 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110022872A (zh) * 2016-11-11 2019-07-16 建明工业 植物提取物用于通过增强的神经发生改善脑健康的应用
CN106727915A (zh) * 2017-01-18 2017-05-31 云南德彩堂生物医药科技有限公司 一种稳定高效提高记忆的组合物及其制备方法和应用
CN110463846A (zh) * 2019-07-30 2019-11-19 河南科技学院 留兰香提取物在制备抗宠物衰老药物或宠物食品中的应用

Also Published As

Publication number Publication date
WO2014026081A1 (en) 2014-02-13
KR101947352B1 (ko) 2019-02-12
CA2880708C (en) 2023-09-26
CA2880708A1 (en) 2014-02-13
KR20150041654A (ko) 2015-04-16
EP2882443B1 (en) 2019-01-16
AU2013299491B2 (en) 2018-03-15
US20250009703A1 (en) 2025-01-09
US20140044813A1 (en) 2014-02-13
EP2882443A4 (en) 2016-01-06
JP2023027232A (ja) 2023-03-01
JP2015524484A (ja) 2015-08-24
JP2021066735A (ja) 2021-04-30
AU2013299491A1 (en) 2015-02-12
JP2025029029A (ja) 2025-03-05
ES2715005T3 (es) 2019-05-31
BR112015002739A2 (pt) 2017-07-04
PL2882443T3 (pl) 2019-06-28
EP2882443A1 (en) 2015-06-17
CN111358832A (zh) 2020-07-03

Similar Documents

Publication Publication Date Title
US20250009703A1 (en) Plant extracts for improving cognitive health and function
Chaudhari et al. Neurocognitive effect of nootropic drug Brahmi (Bacopa monnieri) in Alzheimer's disease
Maczurek et al. Lipoic acid as an anti-inflammatory and neuroprotective treatment for Alzheimer's disease
Hang et al. Nutraceuticals in Parkinson’s disease
Ramassamy et al. Ginkgo biloba extract (EGb 761) in Alzheimer's disease: is there any evidence?
Farr et al. Effect of botanical extracts containing carnosic acid or rosmarinic acid on learning and memory in SAMP8 mice
Zou et al. Neuroprotective effect of peptides extracted from walnut (Juglans Sigilata Dode) proteins on Aβ25-35-induced memory impairment in mice
Sharman et al. Assessment of diets containing curcumin, epigallocatechin-3-gallate, docosahexaenoic acid and α-lipoic acid on amyloid load and inflammation in a male transgenic mouse model of Alzheimer's disease: Are combinations more effective?
Lin et al. Carnosic acid protects SH-SY5Y cells against 6-hydroxydopamine-induced cell death through upregulation of parkin pathway
Smach et al. Effects of sage extract on memory performance in mice and acetylcholinesterase activity
Reza-Zaldívar et al. Comprehensive review of nutraceuticals against cognitive decline associated with Alzheimer’s disease
Meng et al. Comparative analyses of DHA‐phosphatidylcholine forage and liposomes on alzheimer's disease in SAMP8 mice
Cho et al. Neuroprotective effects of Actinidia eriantha cv. Bidan kiwifruit on amyloid beta-induced neuronal damages in PC-12 cells and ICR mice
Singh Neuropharmacological aspects of Crocus sativus L.: a review of preclinical studies and ongoing clinical research
Gupta et al. Nutraceuticals for cognitive dysfunction
Mehta et al. Exploring nordihydroguaretic acid (NDGA) as a plausible neurotherapeutic in the experimental paradigm of autism spectrum disorders targeting nitric oxide pathway
Ghibhela et al. Chapter-3 Brahmi: A Memory Booster Medicinal Herb
Kundu et al. Mechanistic Aspects of Neurodegeneration in Alzheimer’s Disease and the Role of Phytochemicals as Restorative Agents
Zhao Tea Polyphenols and Alzheimer’s
Mary Sheeja et al. Herbal Medicines Used for Neurodegenerative Diseases
Vaibhav et al. Delineation of Neuroprotective Effects and Possible Benefits of AntioxidantsTherapy for the Treatment of Alzheimer’s Diseases by Targeting Mitochondrial-Derived Reactive Oxygen Species: Bench to Bedside
Kundu et al. 13 Mechanistic Neurodegeneration Aspects in of Alzheimer’s Disease and
Jayaraj et al. An Overview of Parkinson's Disease and Oxidative Stress: Herbal Scenario
Reddy Neuroprotective effects of Abelmoschus moschatus seed extract on fluoride-induced myelin degeneration in developing brain of rats
Jun et al. Development of behavioral dysfunction in mice cohabit with brain disordered cage-mate

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
EXSB Decision made by sipo to initiate substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20150603

RJ01 Rejection of invention patent application after publication